Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells.

Bertagnolo V, Marchisio M, Brugnoli F, Bavelloni A, Boccafogli L, Colamussi ML, Capitani S.

Cell Growth Differ. 2001 Apr;12(4):193-200.

PMID:
11331248
[PubMed - indexed for MEDLINE]
Free Article
2.

Views on Vav.

Collins TL, Deckert M, Altman A.

Immunol Today. 1997 May;18(5):221-5. Review. No abstract available.

PMID:
9153953
[PubMed - indexed for MEDLINE]

Supplemental Content

Write to the Help Desk